Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
OtherClinical Care/Education/Nutrition

Evaluation of a Teaching and Treatment Program in Over 4,000 Type 2 Diabetic Patients After Introduction of Reimbursement Policy for Physicians

Stefan Korsatko, Wolfgang Habacher, Ivo Rakovac, Johannes Plank, Sabine Seereiner, Peter Beck, Robert Gfrerer, Peter Mrak, Bernd Bauer, Manfred Großschädl, Thomas R. Pieber
DOI: 10.2337/dc06-2095 Published 1 June 2007
Stefan Korsatko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Wolfgang Habacher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Ivo Rakovac
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Johannes Plank
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Sabine Seereiner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Peter Beck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Robert Gfrerer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Peter Mrak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Bernd Bauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Manfred Großschädl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Thomas R. Pieber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
  • DTTP, diabetes teaching and treatment program

Patient education in diabetes has become an integral part of diabetes management (1–3). Systematic reviews report the best results in terms of improved metabolic control, weight loss, and diabetes-related knowledge in cases where mainly nurses provide patient education combined with structured and regular patient review. Therefore, patient education is recommended as a necessary component in promoting good diabetes control (4,5).

In 2000, the Styrian Diabetes Type 2 Education Project was implemented across the Austrian province of Styria. Until then, no formal implementation or reimbursement of educational efforts had been provided in the Austrian health care system. The primary objective of the project was to provide free access to a structured diabetes teaching and treatment program (DTTP) at the primary health care level throughout the province to patients with type 2 diabetes who are not using insulin for glycemic control. Here, we report its overall acceptance and effectiveness 4 years after its systematic implementation.

RESEARCH DESIGN AND METHODS—

The Styrian Diabetes Type 2 Education Project is a combined intervention consisting of a structured DTTP and a special training for the educating staff. The DTTP is a 16-h course, conducted at the primary health care level. It is well evaluated and transferable (6–10). The program covers nine education areas: basic diabetes information, self-monitoring, medication and hypoglycemia, diet, foot care, physical activity, sick day rules, and late complications. Training of the educators (physicians and diabetes educators) focuses on the discussion of evidence-based therapy and therapy goals. Role-playing techniques are used to improve patient education skills. One year after the initial teaching program, a 2-h refresher course including a follow-up assessment is held. The remuneration for one training course (6–12 participants) is $870 and $183 for the follow-up.

The project is supported by a quality management concept using a documentation form that includes most of the data proposed by the European Diabetes Indicator Project (EUDIP) (11). This form must be completed for each patient at baseline and at follow-up. Every 3 months, a benchmarking report is compiled and sent to each participating physician. An annual report analyzes the effects of the program that suggests adaptations to the steering committee, which reviews current data biannually. A postgraduate meeting is offered twice a year.

RESULTS—

During 4 project years, 120 physicians and 52 diabetes educators taught the DTTP course to 4,396 patients with type 2 diabetes (55% female, aged 63.8 ± 10.7 years, diabetes duration 5.0 ± 6.2 years, BMI 29.7 ± 5.1 kg/m2, baseline A1C 7.6 ± 1.6%; all mean ± SD). A total of 2,122 (48%) individuals attended the follow-up assessment. All target parameters significantly (P < 0.001) improved after 1 year (A1C −0.4 ± 1.3%, BMI −0.4 ± 2.4 kg/m2, body weight −1.1 ± 6.2 kg, systolic blood pressure −1.8 ± 19.3 mmHg, diastolic blood pressure −1.1 ± 10.8 mmHg, cholesterol −0.1 ± 1.1 mmol/l, LDL cholesterol −0.2 ± 0.9 mmol/l, and triglycerides −0.1 ± 1.8 mmol/l). Changes in glucose-lowering treatments are illustrated in Fig. 1. Although insulin therapy was not an inclusion criterion, 1.1% of the patients were already on insulin at baseline and 6% at follow-up. Sixty-six percent of the patients had eye examinations within 1 year before the course and 69% (P = 0.04.) at follow-up. The rate of foot examinations did not change significantly (86–85% at follow-up, P = 0.28).

More information on the project, the documentation form, statistical analysis, baseline characteristics, change in A1C, and treatment for arterial hypertension and blood lipids are available in an online-only appendix (available at http://dx.doi.org/10.2337/dc06-2095).

CONCLUSIONS—

Our evaluation demonstrates that a teaching and treatment program for patients with type 2 diabetes can successfully be implemented throughout the area at the primary health care level. Our large-scale cohort showed an improvement of all target parameters with an A1C reduction comparable to previous randomized studies (12,13). The relative increase of patients treated with biguanides at follow-up may account partly for the decrease of A1C and for the observed weight reduction. Apart from the effects of the training program, including improved drug intake compliance, increase of physical activity patterns, and changes in nutritional habits (9,10), the metabolic improvement could be further explained either by an increase in medication dosage or by initiation of insulin therapy.

The low follow-up rate is a limitation of the project. Randomized controlled trials on similar topics obtain follow-up rates of at least ∼80% (2), while in interrupted time series and before-and-after studies, which are more comparable to our study, these rates are seldom achieved. However, sustained implementation of education programs within the health system has rarely been subject to evaluation in the literature. Through a standardized questionnaire sent to participating physicians, reasons for the low follow-up rate were determined. The most common response was that operating expenses for documentation are too high and that remuneration for the follow-up examination is not attractive. Otherwise, based on physicians' opinions, patients do not show up at follow-up because of loss of motivation, a guilty conscience because they did not modify their behavior after the training course, or they do not see the sense of a follow-up, having already heard everything in the initial course. It is possible that the patients lost to follow-up were less successful in reaching their treatment targets than the others. One can speculate whether a personal reminder for patients, as installed for physicians, would have further increased the follow-up rate.

The introduction of a structured documentation led to a more accurate and comprehensive monitoring of the patient. Eye examination rate (69%) was clearly higher compared with a survey (57.6%) by Saaddine et al. (14). The early educational intervention and intensified screening and treatment for secondary complications in our program will likely postpone the outbreak of diabetes-related comorbidity as previously shown in disease management programs (15,16).

In conclusion, our investigation demonstrates, by means of improved intermediate outcome parameters, that a teaching and treatment program for patients with type 2 diabetes who are not using insulin for glycemic control was successfully implemented province wide at the primary health care level.

Figure 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1—

Change in hypoglycemic treatment before training and at follow-up. Insulin denotes insulin use, either as single therapy or in combination with other oral antidiabetes agents (OAD). Among combinations of OAD, the combination of metformin and sulfonylureas was the most frequent and was prescribed in 55 and 58% of patients receiving >1 OAD at baseline and follow-up, respectively. ▪, before education; □, follow-up.

Acknowledgments

The authors thank all members of Forum for Quality Systems in Diabetes Care, the Styrian Medical Association, the regional health insurance fund (Gebietskrankenkasse), the Styrian government, and all participating physicians and diabetes educators.

Footnotes

  • Published ahead of print at http://care.diabetesjournals.org on 19 March 2007. DOI: 10.2337/dc06-2095.

    Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/dc06-2095.

    A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    • Accepted March 12, 2007.
    • Received October 11, 2006.
  • DIABETES CARE

References

  1. Deakin T, McShane CE, Cade JE, Williams RDRR: Group based training for self-management strategies in people with type 2 diabetes mellitus. The Cochrane Database of Systematic Reviews Issue 2. Art. No.: CD003417.pub2. DOI:10.1002/14651858. CD003417.pub2, 2005
  2. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ: Interventions to improve the management of diabetes in primary care, outpatient and community settings: a systematic review (Review). Diabetes Care 24:1821–1833, 2001
  3. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM: Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25:1159–1171, 2002
  4. Burgers JS, Bailey JV, Klazinga NS, Van Der Bij AK, Grol R, Feder G, AGREE Collaboration: Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 25:1933–1939, 2002
  5. International Diabetes Federation: Global Guideline for Type 2 Diabetes [Internet], 2005. Available from http://www.idf.org/webdata/docs/idf_GGT2D.pdf. Accessed 20 April 2006
  6. Pieber TR, Holler A, Siebenhofer A, Brunner GA, Semlitsch B, Schattenberg S, Zapotoczky H, Rainer W, Krejs GJ: Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria. Diabet Med 12:349–354, 1995
  7. Gagliardino JJ, Etchegoyen G, PENDID-LA Research Group: A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 24:1001–1007, 2001
  8. Mühlhauser I, Berger M: Patient education: evaluation of a complex intervention. Diabetologia 45:1723–1733, 2002
  9. Kronsbein P, Jörgens V, Mühlhauser I, Scholz V, Venhaus A, Berger M: Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet 2:1407–1411, 1998
  10. Grüsser M, Bott U, Ellermann P, Kronsbein P, Jörgens V: Evaluation of a structured treatment and teaching program for non–insulin-treated type 2 diabetic outpatients in Germany after the nationwide introduction of reimbursement policy for physicians. Diabetes Care 16:1268–1275, 1993
  11. Beaufort CE, Reunanen A, Raleigh V, Storms F, Kleinbreil L, Gallego R, Giorda C, Midthjell K, Jecht M, de Leeuw I, Schober E, Boran G, Tolis G: European Union diabetes indicators: fact or fiction? Eur J of Public Health 13 (Suppl.):51–54, 2003
  12. Lozano ML, Armale MJ, Tena DI, Sanchez NC: The education of type-2 diabetics. Aten Primaria 23:485–492, 1999
  13. Brown SA, Garcia AA, Kouzekanani K, Hanis CL: Culturally competent diabetes self-management education for Mexican Americans. Diabetes Care 25:159–168, 2002
  14. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM: A diabetes report card for the United States: quality of care in the 1990's. Ann Intern Med 136:565–574, 2002
  15. Trento M, Passera P, Bajardi M, Tomalino M, Grassi G, Borgo E, Donnola C, Cavallo F, Bondonio P, Porta M: Lifestyle intervention by group care prevents deterioration of type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia 45:1231–1239, 2002
  16. Lavery LA, Wunderlich RP, Tredwell JL: Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract 70:31–37, 2005

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.